Circassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates. Its next-generation immunotherapy is in Phase III testing for cat allergy. Its lead asthma treatment targets substitution of GlaxoSmithKline's (GSK's) Flixotide pMDI. It is developing therapies targeting direct substitution of Seretide pMDI and Serevent pMDI. The Company is also developing a range treatment, including a fixed dose triple combination containing an inhaled corticosteroid, long-acting beta agonist and long-acting muscarinic antagonist.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:CIR
- CUSIP: N/A
- Web: N/A
- Market Cap: £266.83 million
- Outstanding Shares: 284,622,000
- 50 Day Moving Avg: GBX 99.03
- 200 Day Moving Avg: GBX 92.54
- 52 Week Range: GBX 78.45 - GBX 278.60
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £23.1 million
- Price / Sales: 11.55
- Book Value: GBX 0.99 per share
- Price / Book: 0.95
- Average Volume: 163,922 shs.
Frequently Asked Questions for Circassia Pharmaceuticals PLC (LON:CIR)
What is Circassia Pharmaceuticals PLC's stock symbol?
Circassia Pharmaceuticals PLC trades on the London Stock Exchange (LON) under the ticker symbol "CIR."
Where is Circassia Pharmaceuticals PLC's stock going? Where will Circassia Pharmaceuticals PLC's stock price be in 2017?
6 equities research analysts have issued 1-year price objectives for Circassia Pharmaceuticals PLC's stock. Their predictions range from GBX 105 to GBX 174. On average, they anticipate Circassia Pharmaceuticals PLC's stock price to reach GBX 141.50 in the next year. View Analyst Ratings for Circassia Pharmaceuticals PLC.
Who are some of Circassia Pharmaceuticals PLC's key competitors?
Some companies that are related to Circassia Pharmaceuticals PLC include Pendragon PLC (PDG), Mears Group PLC (MER), Redde PLC (REDD), Forterra PLC (FORT), Young & Co.'s Brewery plc (YNGN), Headlam Group plc (HEAD), SDL plc (SDL), GB Group plc (GBG), Consort Medical plc (CSRT), XP Power (XPP), Costain Group PLC (COST), Highland Gold Mining Ltd (HGM), Victoria PLC (VCP), Lookers PLC (LOOK), Biffa PLC (BIFF), 4imprint Group plc (FOUR), Johnson Service Group plc (JSG) and Touchstone Innovations PLC (IVO).
How do I buy Circassia Pharmaceuticals PLC stock?
Shares of Circassia Pharmaceuticals PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Circassia Pharmaceuticals PLC stock cost?
One share of Circassia Pharmaceuticals PLC stock can currently be purchased for approximately GBX 93.75.
Earnings History for Circassia Pharmaceuticals PLC (LON:CIR)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Circassia Pharmaceuticals PLC (LON:CIR)
Current Year EPS Consensus Estimate: $-35.39 EPS
Dividend History for Circassia Pharmaceuticals PLC (LON:CIR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Circassia Pharmaceuticals PLC (LON:CIR)Insider Trades by Quarter for Circassia Pharmaceuticals PLC (LON:CIR)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for Circassia Pharmaceuticals PLC (LON:CIR)
Latest Headlines for Circassia Pharmaceuticals PLC (LON:CIR)
Circassia Pharmaceuticals PLC (CIR) Chart for Saturday, May, 27, 2017